NASDAQ: ACT
Enact Holdings Inc Stock

$31.52+0.37 (+1.19%)
Updated Jan 13, 2025
ACT Price
$31.52
Fair Value Price
$60.46
Market Cap
$4.84B
52 Week Low
$26.13
52 Week High
$37.42
P/E
7.28x
P/B
0.96x
P/S
4.73x
PEG
N/A
Dividend Yield
0.6%
Revenue
$1.20B
Earnings
$682.64M
Gross Margin
96.7%
Operating Margin
77.06%
Profit Margin
57.1%
Debt to Equity
0.31
Operating Cash Flow
$710M
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ACT Overview

Enact Holdings, Inc., a subsidiary of Genworth Holdings, Inc., is a private mortgage insurance company in the U.S. It offers residential mortgage insurance products and contract underwriting services for mortgage lenders. Enact was known as Genworth Mortgage Holdings, Inc. until it changed its name to Enact Holdings, Inc. in 2021/05. The company was founded in 1981 and is headquartered in Raleigh, NC.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ACT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Value
D
Growth
B
Momentum
C
Sentiment
C
Safety
C
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Insurance

Industry Rating
B
ACT
Ranked
#6 of 20

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$19.30B
$217.54B
$85.84B
View Top Specialty Insurance Stocks

Be the first to know about important ACT news, forecast changes, insider trades & much more!

ACT News

Overview

Due Diligence Score

Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ACT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACT ($31.52) is undervalued by 47.87% relative to our estimate of its Fair Value price of $60.46 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACT ($31.52) is significantly undervalued by 47.87% relative to our estimate of its Fair Value price of $60.46 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ACT is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more ACT due diligence checks available for Premium users.

Valuation

ACT fair value

Fair Value of ACT stock based on Discounted Cash Flow (DCF)

Price
$31.52
Fair Value
$60.46
Undervalued by
47.87%
ACT ($31.52) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACT ($31.52) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACT is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
7.28x
Industry
24.26x
Market
29.88x
ACT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ACT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ACT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.96x
Industry
1.6x
ACT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACT's financial health

Profit margin

Revenue
$309.6M
Net Income
$180.7M
Profit Margin
58.4%
ACT's Earnings (EBIT) of $921.79M... subscribe to Premium to read more.
Interest Coverage Financials
ACT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.6B
Liabilities
$1.6B
Debt to equity
0.31
ACT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$188.1M
Investing
-$102.3M
Financing
-$111.5M
ACT's operating cash flow ($710.19M)... subscribe to Premium to read more.
Debt Coverage Financials

ACT vs Specialty Insurance Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ACTC$4.84B+1.19%7.28x0.96x
RDNC$4.65B+1.93%8.02x0.99x
AGOC$4.41B+0.69%6.65x0.77x
MTGB$5.87B+1.27%8.16x1.11x
ESNTC$5.90B+1.89%7.95x1.05x

Enact Holdings Stock FAQ

What is Enact Holdings's quote symbol?

(NASDAQ: ACT) Enact Holdings trades on the NASDAQ under the ticker symbol ACT. Enact Holdings stock quotes can also be displayed as NASDAQ: ACT.

If you're new to stock investing, here's how to buy Enact Holdings stock.

What is the 52 week high and low for Enact Holdings (NASDAQ: ACT)?

(NASDAQ: ACT) Enact Holdings's 52-week high was $37.42, and its 52-week low was $26.13. It is currently -15.77% from its 52-week high and 20.63% from its 52-week low.

How much is Enact Holdings stock worth today?

(NASDAQ: ACT) Enact Holdings currently has 153,589,264 outstanding shares. With Enact Holdings stock trading at $31.52 per share, the total value of Enact Holdings stock (market capitalization) is $4.84B.

Enact Holdings stock was originally listed at a price of $20.49 in Sep 16, 2021. If you had invested in Enact Holdings stock at $20.49, your return over the last 3 years would have been 53.83%, for an annualized return of 15.44% (not including any dividends or dividend reinvestments).

How much is Enact Holdings's stock price per share?

(NASDAQ: ACT) Enact Holdings stock price per share is $31.52 today (as of Jan 13, 2025).

What is Enact Holdings's Market Cap?

(NASDAQ: ACT) Enact Holdings's market cap is $4.84B, as of Jan 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enact Holdings's market cap is calculated by multiplying ACT's current stock price of $31.52 by ACT's total outstanding shares of 153,589,264.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.